Monoclonal Antibodies - Development and Innovative Opportunities in Oncology

Article Abstract:

Herceptin (to treat breast cancer), Mylotarg (to treat non-Hodgkin's Lymphoma), and Rituxan (to treat Acute Myelogenous Leukemia) are but three monoclonial antibodies that have been shown effective in treating cancer.

Product information, Company Planning/Goals, Biological Product (except Diagnostic) Manufacturing, Biological products exc. diagnostic, Monoclonal Antibodies for Therapeutics, Therapeutics, Monoclonal antibodies, Mylotarg (Medication), Herceptin (Medication), Rituxan (Medication)

---

Diabetes, needs/gaps in current treatment

Article Abstract:

Successful management of diabetes begins with an appointment with an endocrinologist. After the patient is educated in the control of his disease a primary care physician can take over his care.

Strategy & planning, Diabetes Therapy, Brief Article

---

Leukemia: immunotherapy is improving outlook

Article Abstract:

The article details the various treatment options for leukemia, their benefits and disadvantages.

Science & research

Similar abstracts:

• Abstracts: Nosocomial infections rates in adult and pediatric intensive care units in the United States. Prevalence and incidence of human immunodeficiency virus among patients undergoing long-term hemodialysis
• Abstracts: Challenges and opportunities for personal selling. Cultivating loyal patients. From fried rice to sushi: to market an integrated delivery system, throw out the old menu
• Abstracts: A theory of health investment under competing mortality risks
• Abstracts: Managed care positives and negatives for health care marketing. Promotional Model: A New Direction for the National Programme on Immunization (NPI) and Oral Rehydration Therapy (ORT) in Nigeria
• Abstracts: Economic conditions and alcohol problems. Healthy living in hard times. Parental leave and child health

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.